Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel in combination with carboplatin for stage IIIB/IV or recurrent non-small cell lung cancer has completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (nab-paclitaxel) (nab-paclitaxel)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Greg Otterson | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-06